Latest news

• 

  16 July 2026

  MOL: USD 100 million interim insurance payment for Danube Refinery fire

  Insurers admitted liability and will pay USD 100 million as an interim settlement; repairs aim to restore full refinery capacity by end-Q3 2026 after an October 2025 unit fire.
• 

  16 July 2026

  SABIC and Rongsheng sign PDA for Jintang New Materials project in Zhoushan

  Evaluating up to 50% stake in Zhoushan advanced-materials project; PDA sets framework toward a potential FID and joint development.
• 

  16 July 2026

  EIB approves €17.4bn financing package including €800m for Cernavodă and Ukraine border upgrades

  €17.4bn package backs energy projects, an €800m Cernavodă loan, securitisation expansion and upgraded Ukraine–EU crossings.
• 

  16 July 2026

  WISA Group Plc: Finnish regulator approves demerger and listing prospectus; leadership team appointed

  Regulator approved the Finnish-language prospectus for the plywood carve-out; EGM, demerger completion and Nasdaq Helsinki listing set for Aug–Nov 2026.
• 

  16 July 2026

  Gasunie positions the Netherlands as Europe’s CO₂ hub

  Five connected CCS projects (Porthos, Aramis, CO₂next, DRC, DSC) will capture, transport and store CO₂ under the North Sea and link industry across the Netherlands, Belgium and Germany.
• 

  16 July 2026

  Lilly to acquire AtaiBeckley to add rapid-acting neuroplastogen pipeline

  Adds BPL-003 (mebufotenin benzoate intranasal) and VLS-01 (DMT buccal); upfront $6.75/share plus up to $2.50/share CVR tied to development, regulatory and DEA-rescheduling milestones.

• 

  16 July 2026

  Merck’s LIPFENDRA — first FDA‑approved once‑daily oral PCSK9 inhibitor

  Oral macrocyclic peptide enlicitide (20 mg) lowers LDL-C ~56–59% at week 24 in Phase 3 trials; approved as adjunct to diet and exercise for adults with hypercholesterolemia, including HeFH.
• 

  16 July 2026

  Uniper supplies Q1 Energie AG with bio‑LNG

  Initial delivery expands bio‑LNG availability for heavy road transport; biomethane is liquefied at Gate Rotterdam, shipped in ISO tanks to Germany and distributed to filling stations.
• 

  16 July 2026

  BASF inaugurates Düsseldorf emollients plant

  Mid double-digit million-euro investment expands capacity for specialty emollients used in skin care and sun protection, serving European and global cosmetics markets.
• 

  16 July 2026

  Evonik completes backward integration of MetAMINO® network with Mobile methyl mercaptan unit

  On-site methyl mercaptan production is now in Antwerp, Singapore and Mobile, completing integration and trimming DL‑methionine’s carbon footprint by ~7% while cutting hazardous intermediate transport.
• 

  16 July 2026

  Air Liquide invests >160M USD in Arizona for ultra‑pure gases for advanced chips

  Arizona plant to supply ultra-high-purity gases for advanced-chip fab expansion using on-site low-carbon hydrogen production and CO2 capture.
• 

  15 July 2026

  Repsol, Toyota, BMW and Bosch pilot cars on 100% renewable gasoline

  Six-month Spanish trial uses existing cars, 100% renewable gasoline and digital tracking to demonstrate drop-in fuel scalability without new vehicles or infrastructure.
• 

  15 July 2026

  Novo Nordisk wins EU authorisation for Wegovy pill and single‑dose 7.2 mg pen

  OASIS data showed ~17% mean weight loss and ~1 in 3 reached ≥20%; safety comparable to injectable semaglutide; wider roll‑out planned in H2 2026.
• 

  15 July 2026

  PureCycle, Mitsui and RM TOHCELLO to bring recycled PP to BOPP film in Japan

  Aiming to introduce recycled polypropylene into BOPP flexible packaging; pilot runs successful and a commercial agreement is targeted for 2027 ahead of shipments subject to import clearance.
• 

  15 July 2026

  DuPont launches end-to-end Direct Lithium Extraction portfolio

  End-to-end DLE suite of 20+ products across sorbents, membranes and ion-exchange resins, plus lab testing, modeling and piloting to tailor flowsheets to varied brine chemistries.
• 

  15 July 2026

  Merck to present daily, weekly and monthly HIV data at AIDS 2026

  Late‑breakers include Week 48 results for once‑weekly islatravir+lenacapavir and Week 24 data for islatravir+ulonivirine; once‑monthly PrEP trials are enrolling.
• 

  15 July 2026

  GSK completes Nuvalent acquisition, adds three NSCLC assets

  Adds three NSCLC assets including two under FDA review for ROS1 and ALK with target decisions later this year; expected 2026 launches; deal valued at ~$10.6bn.
• 

  15 July 2026

  Johnson & Johnson Q2 2026 results and raises 2026 outlook

  Quarterly sales topped $25.3B; adjusted net earnings and EPS rose, free cash flow improved, and full-year revenue guidance was raised above $100B for the first time.
• 

  15 July 2026

  Merck KEYTRUDA improves PFS vs platinum chemotherapy in dMMR endometrial cancer (Phase 3)

  Phase 3 trial finds pembrolizumab monotherapy improves PFS versus platinum doublet chemotherapy in dMMR advanced or recurrent endometrial cancer.
• 

  15 July 2026

  BASF raises 2026 EBITDA outlook after stronger Q2 results

  Q2 sales rose 16% to €17.2bn; EBITDA before special items €2.4bn; net income lifted by a €3.9bn disposal gain; full-year EBITDA guidance raised to €6.9–7.7bn.
• 

  15 July 2026

  Brenntag and Evonik REXIM: exclusive GMP amino acids distribution across most of Europe

  Exclusive agreement transfers market development and distribution of GMP-grade REXIM amino acids across most of Europe to a regional distributor, effective July 1, 2026.
• 

  15 July 2026

  Axens to build France’s first industrial-scale Jetanol™ SAF unit

  50,000 t/y SAF plant using advanced bioethanol and Jetanol™ technology; production targeted for 2030 to boost French/European SAF supply and meet ReFuelEU targets.
• 

  15 July 2026

  Roche: FDA grants Priority Review for Gazyva/Gazyvaro (obinutuzumab) in primary membranous nephropathy

  Priority Review follows MAJESTY phase III showing 36.9% complete remission at two years vs 5.7% with tacrolimus; FDA decision expected by Nov 2026.
• 

  15 July 2026

  Anglo Asian Mining hires Worley for Xarxar and Garadag copper feasibility studies

  Feasibility studies for two Azerbaijan copper deposits will assess heap‑leach and SX‑EW processing; Xarxar due mid‑2027, Garadag H1 2028; ~90,000 m drilling planned.
• 

  14 July 2026

  Sonatrach launches 140,000 m3/day desalination plant construction in Ben M’Hidi, Skikda

  Two-year build to supply Skikda industrial area and ADE; project managed by ADC with works executed by ENAC, both Sonatrach subsidiaries.
• 

  14 July 2026

  Genentech’s Gazyva (obinutuzumab) granted FDA priority review for primary membranous nephropathy

  FDA granted priority review for obinutuzumab in pMN after Phase III MAJESTY showed markedly higher complete remission vs tacrolimus; FDA decision expected Nov 2026.
• 

  14 July 2026

  Olin and Huntsman: SEC Declares S‑4 Effective for Planned Merger

  SEC declared the Form S‑4 effective; special shareholder meetings set for Aug 25; closing expected H1 2027; transaction targets >$400M in synergies and broader vertical integration.
• 

  14 July 2026

  Velocys launches AlphaCore 400 to extend microchannel FT into larger SAF projects

  New higher-capacity microchannel reactor doubles capacity vs AlphaCore 200 to enable larger, lower-cost SAF and synthetic-fuel projects.
• 

  14 July 2026

  PCC SE: Revenue +5–10% to nearly €1bn and EBITDA +20%+ expected in FY2026

  Forecasts revenue near €1bn, EBITDA rising over 20% to a three‑digit million, and a return to EBIT profit; Q2 figures due Aug 20, 2026.
• 

  14 July 2026

  Nobian and Airengy to test AirBattery compressed-air storage in a Danish salt cavern

  Pilot to assess storing surplus renewable electricity as compressed air in a Danish salt cavern for long-duration grid balancing and energy security.